Markov-Randić indices for QSPR re-evaluation of metabolic, parasite-host, fasciolosis spreading, brain cortex and legal-social complex networks

Current Bioinformatics

Volumn 8, Issue 4, 2013, Pages 401-415

  Riera Fernández, Pablo ^a   Munteanu, Cristian R ^b   Martín Romalde, Raquel ^a   Duardo Sánchez, Aliuska ^a,b   González Díaz, Humberto ^c,d  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Brain cortex networks; Complex networks; Connectome; Disease spreading networks; Legal social networks; Markov chains; Metabolic reactions networks; Quantitative structure property relationships; Topological indices

Indexed keywords

CHAINS; COMPUTATIONAL CHEMISTRY; MARKOV PROCESSES; METABOLISM; QUALITY CONTROL; TOPOLOGY;

BRAIN CORTEX; BRAIN CORTEX NETWORK; CONNECTOMES; DISEASE SPREADING; DISEASE SPREADING NETWORK; LEGAL-SOCIAL NETWORK; METABOLIC REACTION NETWORK; METABOLIC REACTIONS; QUANTITATIVE STRUCTURE PROPERTY RELATIONSHIPS; REACTION NETWORK; TOPOLOGICAL INDEX;

COMPLEX NETWORKS;

BRAIN CORTEX; COMPUTER PROGRAM; CONNECTOME; DISCRIMINANT ANALYSIS; DISEASE TRANSMISSION; FASCIOLIASIS; FINANCIAL MANAGEMENT; HEALTH CARE QUALITY; HOST PARASITE INTERACTION; HUMAN; LAW; MARKOV RANDIC INDEX; MATHEMATICAL ANALYSIS; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE STRUCTURE PROPERTY RELATION; REVIEW; SOCIAL NETWORK; STATISTICAL MODEL;

EID: 84882778686     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574893611308040003     Document Type: Review

References (140)

1. Consonni V, Todeschini R. Molecular descriptors. In: Puzyn T, Leszczynski J, Cronin MTD, ed.^eds., Recent advances in QSAR studies: Methods and Applications. Springer, 2010; pp. 29-102.
2. Doucet JP, Panaye A. Three dimensional QSAR: Applications in Pharmacology and Toxicology. CRC press: Boca Raton 2010.
3. Katritzky AR, Gordeeva EV. Traditional topological indices vs electronic, geometrical, and combined molecular descriptors in QSAR/QSPR research. J Chem Inf Comput Sci 1993; 33: 835-57.
4. Randić M. Characterization of molecular branching. J Am Chem Soc 1975; 97: 6609-6615.
5. Randić M. On characterization of molecular attribute. Acta Chim Slov 1998; 45: 239-252.
6. Estrada E. The structural interpretation of the randi index. Internet Electronic J Mol Design 2002; 1: 360-366.
7. Kier LB, Murray WJ, Randić M, Hall LH. Molecular connectivity I: Relationship to nonspecific local anesthesia. J Pharm Sci 1975; 64: 1971-1974.
8. Bornholdt S, Schuster HG. Handbook of Graphs and Complex Networks: From the Genome to the Internet. WILEY-VCH GmbH & CO. KGa.: Wheinheim 2003.
9. Boccaletti S, Latora V, Moreno Y, Chavez M, Hwang DU. Complex networks: Structure and dynamics. Phys Reports 2006; 424: 175-308.
10. Dehmer M, Emmert-Streib F eds. Analysis of complex networks: From biology to linguistics. Wiley-Blackwell: Wheinheim 2009.
11. Newman M. The Structure and Function of Complex Networks. SIAM Review, 2003: 167-256.
12. Puzyn T, Leszczynski J, Cronin MTD eds. Recent Advances in QSAR Studies: Methods and applications. Springer 2010.
13. González-Díaz H, Munteanu CR eds. Topological Indices for Medicinal Chemistry, Biology, Parasitology, Neurological and Social Networks. Transworld Research Network Kerala (India) 2010.
14. Caballero J, Fernandez M. Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem 2008; 8: 1580-605.
15. Duardo-Sanchez A, Patlewicz G, Lopez-Diaz A. Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues. Curr Top Med Chem 2008; 8: 1666-75.
16. Gonzalez MP, Teran C, Saiz-Urra L, Teijeira M. Variable selection methods in QSAR: an overview. Curr Top Med Chem 2008; 8: 1606-27.
17. Gonzalez-Diaz H. Quantitative studies on Structure-Activity and Structure-Property Relationships (QSAR/QSPR). Curr Top Med Chem 2008; 8: 1554.
18. Gonzalez-Diaz H, Prado-Prado F, Ubeira FM. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr Top Med Chem 2008; 8: 1676-90.
19. Helguera AM, Combes RD, Gonzalez MP, Cordeiro MN. Applications of 2D descriptors in drug design: a DRAGON tale. Curr Top Med Chem 2008; 8: 1628-55.
20. Ivanciuc O. Weka machine learning for predicting the phospholipidosis inducing potential. Curr Top Med Chem 2008; 8: 1691-709.
21. Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 2008; 8: 1555-72.
22. Wang JF, Wei DQ, Chou KC. Drug candidates from traditional chinese medicines. Curr Top Med Chem 2008; 8: 1656-65.
23. Wang JF, Wei DQ, Chou KC. Pharmacogenomics and personalized use of drugs. Curr Top Med Chem 2008; 8: 1573-9.
24. Torrens F, Castellano G. Topological Charge-Transfer Indices: From Small Molecules to Proteins. Curr Proteomics 2009: 204-213.
25. Ivanciuc O. Machine learning Quantitative Structure-Activity Relationships (QSAR) for peptides binding to Human Amphiphysin-1 SH3 domain. Curr Proteomics 2009; 4: 289-302.
26. Giuliani A, Di Paola L, Setola R. Proteins as Networks: A Mesoscopic Approach Using Haemoglobin Molecule as Case Study. Curr Proteomics 2009; 6: 235-245.
27. Chou KC. Pseudo amino acid composition and its applications in bioinformatics, proteomics and system biology. Curr Proteomics 2009; 6: 262-274.
28. Chen J, Shen B. Computational Analysis of Amino Acid Mutation: a Proteome Wide Perspective. Curr Proteomics 2009; 6: 228-234.
29. Zhong WZ, Zhan J, Kang P, Yamazaki S. Gender specific drug metabolism of PF-02341066 in rats--role of sulfoconjugation. Curr Drug Metab 2010; 11: 296-306.
30. Wang JF, Chou KC. Molecular modeling of cytochrome P450 and drug metabolism. Curr Drug Metab 2010; 11: 342-6.
31. Mrabet Y, Semmar N. Mathematical methods to analysis of topology, functional variability and evolution of metabolic systems based on different decomposition concepts. Curr Drug Metab 2010; 11: 315-41.
32. Martinez-Romero M, Vazquez-Naya JM, et al. Artificial intelligence techniques for colorectal cancer drug metabolism: ontology and complex network. Curr Drug Metab 2010; 11: 347-68.
33. Khan MT. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr Drug Metab 2010; 11: 285-95.
34. Gonzalez-Diaz H, Duardo-Sanchez A, Ubeira FM, et al. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers. Curr Drug Metab 2010; 11: 379-406.
35. Gonzalez-Diaz H. Network topological indices, drug metabolism, and distribution. Curr Drug Metab 2010; 11: 283-4.
36. Garcia I, Diop YF, Gomez G. QSAR & complex network study of the HMGR inhibitors structural diversity. Curr Drug Metab 2010; 11: 307-14.
37. Chou KC. Graphic rule for drug metabolism systems. Curr Drug Metab 2010; 11: 369-78.
38. Concu R, Podda G, Ubeira FM, Gonzalez-Diaz H. Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organisms. Curr Pharm Design 2010; 16: 2710-23.
39. Estrada E, Molina E, Nodarse D, Uriarte E. Structural Contributions of Substrates to their Binding to P-Glycoprotein. A TOPS-MODE Approach. Curr Pharm Design 2010; 16: 2676-709.
40. Garcia I, Fall Y, Gomez G. QSAR, docking, and CoMFA studies of GSK3 inhibitors. Curr Pharm Design 2010; 16: 2666-75.
41. Gonzalez-Diaz H. QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences. Curr Pharm Design 2010; 16: 2598-600.
42. Gonzalez-Diaz H, Romaris F, Duardo-Sanchez A, et al. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues. Curr Pharm Design 2010; 16: 2737-64.
43. Marrero-Ponce Y, Casanola-Martin GM, Khan MT, Torrens F, Rescigno A, Abad C. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds. Curr Pharm Design 2010; 16: 2601-24.
44. Munteanu CR, Fernandez-Blanco E, Seoane JA, et al. Drug discovery and design for complex diseases through QSAR computational methods. Curr Pharm Design 2010; 16: 2640-55.
45. Roy K, Ghosh G. Exploring QSARs with Extended Topochemical Atom (ETA) indices for modeling chemical and drug toxicity. Curr Pharm Design 2010; 16: 2625-39.
46. Speck-Planche A, Scotti MT, de Paulo-Emerenciano V. Current pharmaceutical design of antituberculosis drugs: future perspectives. Curr Pharm Design 2010; 16: 2656-65.
47. Vazquez-Naya JM, Martinez-Romero M, Porto-Pazos AB, et al. Ontologies of drug discovery and design for neurology, cardiology and oncology. Curr Pharm Design 2010; 16: 2724-36.
48. García I, Fall Y, Gómez G. Trends in Bioinformatics and Chemoinformatics of Vitamin D analogues and their protein targets. Curr Bioinform 2011; 6: 16-24.
49. Chiş O, Dumitru O, Concu R, Shen B. Reviewing Yeast Network and report of new Stochastic-Credibility cell cycle models. Curr Bioinform 2011; 6: 35-43.
50. Duardo-Sanchez A, Patlewicz G, González-Díaz H. A Review of Network Topological Indices from Chem-Bioinformatics to Legal Sciences and back. Curr Bioinform 2011; 6: 53-70.
51. Bhattacharjee B, Jayadeepa RM, Banerjee S, et al. Review of Complex Network and Gene Ontology in pharmacology approaches: Mapping natural compounds on potential drug target Colon Cancer network. Curr Bioinform 2011; 6: 44-52.
52. Prado-Prado F, Escobar-Cubiella M, García-Mera X. Review of Bioinformatics and QSAR studies of -secretase inhibitors. Curr Bioinform 2011; 6: 3-15.
53. Ivanciuc T, Ivanciuc O, Klein DJ. Network-QSAR with Reaction Poset Quantitative Superstructure-Activity Relationships (QSSAR) for PCB Chromatographic Properties. Curr Bioinform 2011; 6: 25-34.
54. Wan SB, Hu LL, Niu S, et al. Identification of multiple subcellular locations for proteins in budding yeast. Curr Bioinform 2011; 6: 71-80.
55. Riera-Fernández P, Munteanu CR, Pedreira-Souto N, Martín-Romalde R, Duardo-Sanchez A, González-Díaz H. Definition of Markov-Harary Invariants and Review of Classic Topological Indices and Databases in Biology, Parasitology, Technology, and Social-Legal Networks. Curr Bioinform 2011; 6: 94-121.
56. Dave K, Banerjee A. Bioinformatics analysis of functional relations between CNPs regions. Curr Bioinform 2011; 6: 122-128.
57. Speck-Planche A, Cordeiro MNDS. Application of Bioinformatics for the search of novel anti-viral therapies: Rational design of antiherpes agents. Curr Bioinform 2011; 6: 81-93.
58. Gonzalez-Diaz H, Duardo-Sanchez A, Ubeira FM, et al. Review of MARCH-INSIDE & Complex Networks Prediction of Drugs: ADMET, Anti-parasite Activity, Metabolizing Enzymes and Cardiotoxicity Proteome Biomarkers. Curr Drug Metab 2010; 11: 379-406.
59. Modha DS, Singh R. Network architecture of the long-distance pathways in the macaque brain. Proc Natl Acad Sci USA 2010; 107: 13485-90.
60. Randić M. The connectivity index 25 years after. J Mol Graph Model 2001; 20: 19-35.
61. Randić M. On History of the Randić Index and Emerging Hostility toward Chemical Graph Theory. Commun Math Comput Chem 2008; 59: 5-124.
62. Hall LH, Kier LB, Murray WJ. Molecular connectivity. II: Relationship to water solubility and boiling point. J Pharm Sci 1975; 64: 1974-7.
63. Murray WJ, Hall LH, Kier LB. Molecular connectivity. III: Relationship to partition coefficients. J Pharm Sci 1975; 64: 1978-81.
64. Kier LB, Murray WJ, Hall LH. Molecular connectivity. 4. Relationships to biological activities. J Med Chem 1975; 18: 1272-4.
65. Kier LB, Murray WJ, Randic M, Hall LH. Molecular connectivity V: connectivity series concept applied to density. J Pharm Sci 1976; 65: 1226-30.
66. Murray WJ, Kier LB, Hall LH. Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity. J Med Chem 1976; 19: 573-8.
67. Kier LB, Hall LH. Molecular connectivity VII: specific treatment of heteroatoms. J Pharm Sci 1976; 65: 1806-9.
68. Hall LH, Kier LB. Issues in representation of molecular structure the development of molecular connectivity. J Mol Graph Model 2001; 20: 4-18.
69. Kier LB, Hall LH. Molecular Connectivity in Chemistry and Drug Research. Academic Press: New York 1976.
70. Kier LB, Hall LH. Molecular Connectivity in Structure-Activity Analysis. Research Studies Press: Letchworth (England) 1986.
71. Kier LB, Hall LH. Molecular Structure Description: The Electrotopological State Analysis. Academic Press: San Diego 1999.
72. Kier LB, Hall LH. Molecular connectivity VII: Specific treatment to heteroatoms. J Pharm Sci 1976; 65: 1806-1809.
73. Randić M. Novel graph theoretical approach to heteroatoms in quantitative structure-activity relationships. Chemomet Int Lab Syst 1991; 10: 213-227.
74. Randić M. On computation of optimal parameters for multivariate analysis of structure-property relationship. J Comput Chem 1991; 12: 970-980.
75. Todeschini R, Consonni V. Molecular Descriptors for Chemoinformatics. Wiley-VCH: Weinheim 2009.
76. Amidon GL, Anik ST. Comparison of several molecular topological indexes with molecular surface area in aqueous solubility estimation. J Pharm Sci 1976; 65: 801-6.
77. Katritzky AR, Oliferenko AA, Oliferenko PV, et al. A general treatment of solubility. 1. The QSPR correlation of solvation free energies of single solutes in series of solvents. J Chem Inf Comput Sci 2003; 43: 1794-805.
78. Bollobás B, Erdos P. Graphs of extremal weights. Ars Combinatoria 1998; 50: 225-233.
79. Bollobás B, Erdos P, Sarkar A. Extremal graphs for weights. Ars Combinatoria 1999; 200: 5-19.
80. Gutman I. Chemical graph theory - the mathematical connection. Adv Quantum Chem 2006; 51: 125-138.
81. Li X, Gutman I. Mathematical Aspects of Randic-type Molecular Structure Descriptors. University of Kragujevac: Kragujevac (Serbia) 2006.
82. Estrada E. Randić Index, Irregularity and Complex Biomolecular Networks. Acta Chim Slov 2010; 57: 597-603.
83. Albertson MO. The Irregularity of a Graph. Ars Combinatoria 1997; 46: 219-225.
84. Biggs N. Algebraic graph theory. Cambridge University Press: Cambridge 1974.
85. Mohar B. Some applications of Laplace eigenvalues of graphs. In: Hahn G, Sabidussi G, ed.^eds., Graph Symmetry: Algebraic Methods and Applications. Kluwer 1997; pp. 444.
86. Biyikoglu T, Leydold J, Stadler PF. Laplacian Eigenvector of Graphs. Springer 2007.
87. Bonchev D. Overall connectivity-a next generation molecular connectivity. J Mol Graph Model 2001; 20: 65-75.
88. Zhou B, Trinajstić N. On a novel connectivity index. J Math Chem 2009; 46: 1252-1270.
89. Valderrama JO, Rojas RE. Mass connectivity index, a new molecular parameter for the estimation of ionic liquid properties. Fluid Phase Equilibria 2010; 297: 107-112
90. Berca MN, Duardo-Sanchez A, González-Díaz H, Pazos A, Munteanu CR. Markov entropy for biology, parasitology, linguistic, technology, social and law networks. In: González-Díaz H, Prado-Prado FJ, García-Mera X, ed.^eds., Complex Network Entropy: From Molecules to Biology, Parasitology, Technology, Social, Legal, and Neurosciences. Transworld Research Network: Kerala, India, 2011; pp. 127-142.
91. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL. The largescale organization of metabolic networks. Nature 2000; 407: 651-4.
92. Arai HP, Mudry DR. Protozoan and metazoan parasites of fishes from the headwaters of the Parsnip and McGregor Rivers, British Columbia: a study of possible parasite transfaunations. Canadian J Fisheries Aquatic Sci 1983; 40: 1676-1684.
93. Arthur JR, Margolis L, Arai HP. Parasites of fishes of Aishihik and Stevens Lakes, Yukon Territory, and potential consequences of their interlake transfer through a proposed water diversion for hydroelectrical purposes. J Fisheries Res Board Canada 1976; 33: 2489-2499.
94. Bangham RV. Studies on fish parasites of Lake Huron and Manitoulin Island. Am Midland Naturalist 1955; 53: 184-194.
95. Chinniah VC, Threlfall W. Metazoan parasites of fish from the Smallwood Reservoir, Labrador, Canada. J Fish Biol 1978; 13.
96. Dechtiar AO. Parasites of fish from Lake of the Woods, Ontario. J Fisheries Res Board Canada 1972; 29: 275-283.
97. Leong TS, Holmes JC. Communities of metazoan parasites in open water fishes of Cold Lake, Alberta. J Fish Biol 1981; 18: 693-713.
98. Nunn CL, Altizer SM. The Global Mammal Parasite Database: An Online Resource for Infectious Disease Records in Wild Primates. Evol Anthropol 2005; 14: 1-2.
99. Mezo M, Gonzalez-Warleta M, Castro-Hermida JA, Ubeira FM. Evaluation of the flukicide treatment policy for dairy cattle in Galicia (NW Spain). Vet Parasitol 2008; 157: 235-43.
100. González-Díaz H, Mezo M, González-Warleta M, Muíño-Pose L, Paniagua E, Ubeira FM. Network prediction of fasciolosis spreading in Galicia (NW Spain). In: González-Díaz H, Munteanu CR, ed.^eds., Topological Indices for Medicinal Chemistry, Biology, Parasitology, Neurological and Social Networks. Transworld Research Network: Kerala (India), 2010; pp. 191-204.
101. Riera-Fernandez P, Munteanu CR, Escobar M, et al. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks. J Theor Biol 2012; 293: 174-88.
102. Hill T, Lewicki P. Statistics Methods and Applications. A Comprehensive Reference for Science, Industry and Data Mining. StatSoft: Tulsa 2006.
103. Junker BH, Koschuetzki D, Schreiber F. Exploration of biological network centralities with CentiBiN. BMC Bioinformatics 2006; 7: 219.
104. Batagelj V, Mrvar A. Pajek: A program for large network analysis. Connections 1998; 21: 47-57.
105. De Nooy W, Mrvar A, Batagelj V. Exploratory Social network analysis with Pajek. Cambridge University Press: Cambridge 2005.
106. Rosa da Silva M, Sun J, Ma HW, He F, Zeng AP. Metabolic networks. In: Junker BH, Schreiber F, ed.^eds., Analysis of biological networks. Wiley & Sons: New Jersey, 2008; pp. 233-253.
107. Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabasi AL. The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 2008; 105: 9880-5.
108. Baldazzi V, Ropers D, Markowicz Y, Kahn D, Geiselmann J, de Jong H. The carbon assimilation network in Escherichia coli is densely connected and largely sign-determined by directions of metabolic fluxes. PLoS Comput Biol 2010; 6: e1000812.
109. Costa RS, Machado D, Rocha I, Ferreira EC. Hybrid dynamic modeling of Escherichia coli central metabolic network combining Michaelis-Menten and approximate kinetic equations. Biosystems 2010; 100: 150-7.
110. Gerlee P, Lizana L, Sneppen K. Pathway identification by network pruning in the metabolic network of Escherichia coli. Bioinformatics 2009; 25: 3282-8.
111. Fowler ZL, Gikandi WW, Koffas MA. Increased malonyl coenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its application to flavanone production. Appl Environ Microbiol 2009; 75: 5831-9.
112. Konig R, Schramm G, Oswald M, et al. Discovering functional gene expression patterns in the metabolic network of Escherichia coli with wavelets transforms. BMC Bioinformatics 2006; 7: 119.
113. Imielinski M, Belta C, Rubin H, Halasz A. Systematic analysis of conservation relations in Escherichia coli genome-scale metabolic network reveals novel growth media. Biophys J 2006; 90: 2659-72.
114. Shi H, Nikawa J, Shimizu K. Effect of modifying metabolic network on poly-3-hydroxybutyrate biosynthesis in recombinant Escherichia coli. J Biosci Bioeng 1999; 87: 666-77.
115. Lin H, Bennett GN, San KY. Chemostat culture characterization of Escherichia coli mutant strains metabolically engineered for aerobic succinate production: a study of the modified metabolic network based on metabolite profile, enzyme activity, and gene expression profile. Metab Eng 2005; 7: 337-52.
116. Ghim CM, Goh KI, Kahng B. Lethality and synthetic lethality in the genome-wide metabolic network of Escherichia coli. J Theor Biol 2005; 237: 401-11.
117. Schmid JW, Mauch K, Reuss M, Gilles ED, Kremling A. Metabolic design based on a coupled gene expression-metabolic network model of tryptophan production in Escherichia coli. Metab Eng 2004; 6: 364-77.
118. Light S, Kraulis P. Network analysis of metabolic enzyme evolution in Escherichia coli. BMC Bioinformatics 2004; 5: 15.
119. Burgard AP, Maranas CD. Probing the performance limits of the Escherichia coli metabolic network subject to gene additions or deletions. Biotechnol Bioeng 2001; 74: 364-75.
120. Edwards JS, Palsson BO. Robustness analysis of the Escherichia coli metabolic network. Biotechnol Progress 2000; 16: 927-39.
121. Goffeau A. The yeast genome directory. Nature 1997; 387: 5.
122. Burglin TR, Lobos E, Blaxter ML. Caenorhabditis elegans as a model for parasitic nematodes. Int J Parasitol 1998; 28: 395-411.
123. Consortium TCeS. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 1998; 282: 2012-8.
124. Bird DM, Opperman CH. Caenorhabditis elegans: A Genetic Guide to Parasitic Nematode Biology. J Nematol 1998; 30: 299-308.
125. Holden-Dye L, Walker RJ. Anthelmintic drugs. WormBook 2007: 1-13.
126. Muller B, Grossniklaus U. Model organisms-A historical perspective. J Proteomics 2010; 73: 2054-63.
127. Desdevises Y, Morand S, Legendre P. Evolution and determinants of host specificity in the genus Lamellodiscus (Monogenea). Biol J Linnean Soc 2002; 77: 431-443.
128. Detwiler J, Janovy Jr. J. The role of phylogeny and ecology in experimental host specificity: Insights from a eugregarine-host system. J Parasitol 2008; 94: 7-12.
129. Poulin R, Krasnov BR, Mouillot D. Host specificity in phylogenetic and geographic space. Trends Parasitol 2011; In press.
130. Hatcher JM, Dick JTA, Dunn AM. How parasites affect interactions between competitors and predators. Ecol Lett 2006; 9: 1253-1271.
131. Price PW, Westoby M, Rice B, et al. Parasite Mediation in Ecological Interactions. Ann Rev Ecol Syst 1986; 17: 485-505.
132. Anderson RM, May RM. Population biology of infectious diseases: Part I. Nature 1979; 280: 361-367.
133. Poulin R. Network analysis shining light on parasite ecology and diversity. Trends Parasitol 2010; 26: 492-8.
134. Kotter R. Online retrieval, processing, and visualization of primate connectivity data from the CoCoMac database. Neuroinformatics 2004; 2: 127-44.
135. Stephan KE, Kamper L, Bozkurt A, Burns GA, Young MP, Kotter R. Advanced database methodology for the Collation of Connectivity data on the Macaque brain (CoCoMac). Philos Trans R Soc Lond B Biol Sci 2001; 356: 1159-86.
136. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005; 79: 207-16.
137. Wasserman S, Faust K. Social network analysis: methods and applications. Cambridge University Press: Cambridge 1999.
138. Fowler JH, Jeon S. The authority of Supreme Court precedent. Soc Networks 2008; 30: 16-30.
139. Duardo-Sánchez A. Study of criminal law networks with Markovprobability centralities. In: González-Díaz H, ed.^eds., Topological Indices for Medicinal Chemistry, Biology, Parasitology, Neurological and Social Networks. Bentham: Kerala, India, 2010; pp. 205-212.
140. Duardo-Sánchez A. Criminal law networks, markov chains, Shannon entropy and artificial neural networks. In: González-Díaz H, ed.^eds., Complex Network Entropy: From Molecules to Biology, Parasitology, Technology, Social, Legal, and Neurosciences. Bentham: Kerala, India, 2011; pp. 107-114.